Total Payments
$3,140
2024 Payments
$231.45
Companies
28
Transactions
98
Medicare Patients
711
Medicare Billing
$81,616
Payment Breakdown by Category
Food & Beverage$3,140 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,140 | 98 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $574.41 | 5 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $366.02 | 11 | $0 (2022) |
| PFIZER INC. | $354.56 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $228.22 | 10 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $204.85 | 8 | $0 (2024) |
| Novo Nordisk Inc | $183.49 | 4 | $0 (2019) |
| AbbVie Inc. | $151.88 | 7 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $144.02 | 2 | $0 (2018) |
| Kowa Pharmaceuticals America, Inc. | $139.70 | 1 | $0 (2017) |
| Celgene Corporation | $113.41 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $231.45 | 7 | Celgene Corporation ($113.41) |
| 2023 | $322.27 | 12 | Novartis Pharmaceuticals Corporation ($166.32) |
| 2022 | $241.19 | 12 | PFIZER INC. ($46.40) |
| 2021 | $339.01 | 17 | PFIZER INC. ($92.41) |
| 2020 | $272.55 | 14 | Janssen Pharmaceuticals, Inc ($79.58) |
| 2019 | $279.48 | 7 | Novo Nordisk Inc ($119.79) |
| 2018 | $378.23 | 10 | AstraZeneca Pharmaceuticals LP ($131.90) |
| 2017 | $1,076 | 19 | Allergan Inc. ($552.70) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/28/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: VACCINES | ||||||
| 04/26/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $113.41 | General |
| 03/15/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Inflammation | ||||||
| 03/02/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Respiratory | ||||||
| 09/27/2023 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $66.41 | General |
| 07/26/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/12/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/11/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/29/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/19/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/26/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: VACCINES | ||||||
| 03/01/2023 | Novartis Pharmaceuticals Corporation | KYMRIAH (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Oncology | ||||||
| 02/17/2023 | Novartis Pharmaceuticals Corporation | KYMRIAH (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Oncology | ||||||
| 02/15/2023 | Novartis Pharmaceuticals Corporation | KYMRIAH (Drug) | Food and Beverage | In-kind items and services | $58.18 | General |
| Category: Oncology | ||||||
| 10/23/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: RESPIRATORY | ||||||
| 10/19/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/13/2022 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: Immunology | ||||||
| 05/13/2022 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $0.65 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 60 | 190 | $33,247 | $11,319 |
| 2022 | 4 | 149 | 316 | $56,342 | $19,365 |
| 2021 | 5 | 201 | 475 | $48,478 | $25,162 |
| 2020 | 9 | 301 | 595 | $47,073 | $25,770 |
Total Patients
711
Total Services
1,576
Medicare Billing
$81,616
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 190 | $33,247 | $11,319 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 234 | $42,513 | $14,282 | 33.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 31 | 58 | $10,498 | $3,418 | 32.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 11 | 11 | $2,874 | $1,431 | 49.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 13 | 13 | $457.00 | $234.58 | 51.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 90 | 233 | $30,064 | $15,145 | 50.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 44 | 44 | $7,626 | $4,705 | 61.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 23 | 114 | $5,700 | $2,937 | 51.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 16 | 23 | $2,842 | $1,218 | 42.9% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 28 | 61 | $2,246 | $1,157 | 51.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 91 | 227 | $24,743 | $10,772 | 43.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 56 | 56 | $8,400 | $6,447 | 76.8% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 27 | 125 | $6,250 | $3,704 | 59.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 43 | 84 | $2,100 | $1,523 | 72.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 17 | $2,720 | $1,446 | 53.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 30 | $1,350 | $886.25 | 65.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 33 | 33 | $660.00 | $580.92 | 88.0% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 11 | 11 | $550.00 | $210.87 | 38.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 12 | 12 | $300.00 | $198.84 | 66.3% |
About Dr. Carlos Silva, MD
Dr. Carlos Silva, MD is a Internal Medicine healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275577694.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carlos Silva, MD has received a total of $3,140 in payments from pharmaceutical and medical device companies, with $231.45 received in 2024. These payments were reported across 98 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,140).
As a Medicare-enrolled provider, Silva has provided services to 711 Medicare beneficiaries, totaling 1,576 services with total Medicare billing of $81,616. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Tampa, FL
- Active Since 06/15/2006
- Last Updated 05/29/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275577694
Products in Payments
- ELIQUIS (Drug) $285.36
- NAMENDA XR (Drug) $278.84
- LINZESS (Drug) $273.86
- XARELTO (Drug) $253.61
- TOUJEO (Drug) $144.02
- Livalo (Drug) $139.70
- VRAYLAR (Drug) $137.03
- Ozempic (Drug) $119.79
- Vascepa (Drug) $113.33
- INVOKANA (Drug) $112.41
- ENTRESTO (Drug) $102.42
- FARXIGA (Drug) $101.60
- KYMRIAH (Drug) $84.42
- TRELEGY ELLIPTA (Drug) $67.61
- SYMBICORT (Drug) $54.87
- TRULICITY (Drug) $44.95
- Victoza (Drug) $41.42
- LEQVIO (Drug) $41.38
- XIFAXAN (Drug) $39.16
- PREVNAR 20 (Biological) $38.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tampa
Javier Pinilla-Ibarz, Md, MD
Internal Medicine — Payments: $1.9M
Internal Medicine $1.9M
Alberto Chiappori, Md, MD
Internal Medicine — Payments: $617,120
Internal Medicine $617,120
Ricardo Restrepo-Jaramillo, M.d, M.D
Internal Medicine — Payments: $562,511
Internal Medicine $562,511
Dr. Sady Alpizar, Md, MD
Internal Medicine — Payments: $509,824
Internal Medicine $509,824
Jhanelle Gray, Md, MD
Internal Medicine — Payments: $273,892
Internal Medicine $273,892
Dr. Andrew Kuykendall, M.d, M.D
Internal Medicine — Payments: $273,357
Internal Medicine $273,357